The CLINICAL VIROLOGY CORE serves as a central laboratory for clinical and basic investigators in the California University wide Task Force on AIDS, the UC Davis Medical Center in Sacramento, the PRIMATE CENTER CORE, and the MOLECULAR VIROLOGY CORE. The CLINICAL VIROLOGY CORE will provide the equipment, materials and expertise to support projects that require laboratory diagnostic tests for retrovirus infections or retrovirus cell culture under biocontainment level 3 (BL 3) conditions. These projects involve several retroviruses including HIV-l, HIV-2, HTLV-l, STLV-I, SIVmac and SIVsm. Diagnostic methods include primary virus isolation and culture with adaptation of isolates to continuous cell lines, serologies for the detection of antiviral antibodies or viral antigens, eg., HIV p24, immunohistochemical methods, and other indicators of disease progression including beta-2-microglobulin and T-cell levels. Retrovirus cell culture methods are applied to projects that require large scale production and purification of retrovirus antigens, analysis of inactivation or neutralization of retrovirus infectivity, and other in vitro retrovirology experiments. The CLINICAL VIROLOGY CORE supports a central role in the collection, processing, accessioning, and triage of specimens from both human and simian sources.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Davis
United States
Zip Code
Yamanaka, M K; Yilma, T (1998) Altered plaque formation by recombinant vaccinia virus expressing simian immunodeficiency virus Nef. J Virol 72:5291-5
Giavedoni, L D; Yilma, T (1996) Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J Virol 70:2247-51
Gardner, M; Rosenthal, A; Jennings, M et al. (1995) Passive immunization of rhesus macaques against SIV infection and disease. AIDS Res Hum Retroviruses 11:843-54
Luciw, P A; Pratt-Lowe, E; Shaw, K E et al. (1995) Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci U S A 92:7490-4
Anderson, D E; Malley, A; Benjamini, E et al. (1994) Hypervariable epitope constructs as a means of accounting for epitope variability. Vaccine 12:736-40
Gardner, M B; Rosenthal, A; Jennings, M et al. (1994) Passive immunization of macaques against SIV infection. J Med Primatol 23:164-74
Ahmad, S; Lohman, B; Marthas, M et al. (1994) Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses 10:195-204
Herchenroder, O; Renne, R; Loncar, D et al. (1994) Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201:187-99
Torres, J V; Malley, A; Banapour, B et al. (1993) An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res Hum Retroviruses 9:423-30
Yamamoto, J K; Hohdatsu, T; Olmsted, R A et al. (1993) Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol 67:601-5

Showing the most recent 10 out of 25 publications